A detailed history of Thrivent Financial For Lutherans transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 36,223 shares of PCRX stock, worth $705,261. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,223
Previous 38,640 6.26%
Holding current value
$705,261
Previous $1.11 Million 50.68%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$11.7 - $28.46 $28,278 - $68,787
-2,417 Reduced 6.26%
36,223 $545,000
Q2 2024

Aug 13, 2024

SELL
$25.5 - $31.51 $719,712 - $889,338
-28,224 Reduced 42.21%
38,640 $1.11 Million
Q1 2024

May 14, 2024

SELL
$27.7 - $35.48 $306,001 - $391,947
-11,047 Reduced 14.18%
66,864 $1.95 Million
Q4 2023

Feb 14, 2024

SELL
$26.32 - $34.31 $364,453 - $475,090
-13,847 Reduced 15.09%
77,911 $2.63 Million
Q3 2023

Nov 14, 2023

BUY
$30.68 - $40.09 $1.47 Million - $1.91 Million
47,764 Added 108.57%
91,758 $2.82 Million
Q2 2023

Aug 14, 2023

SELL
$36.12 - $47.5 $53,313 - $70,110
-1,476 Reduced 3.25%
43,994 $1.76 Million
Q1 2023

May 17, 2023

SELL
$35.53 - $43.38 $56,599 - $69,104
-1,593 Reduced 3.38%
45,470 $1.86 Million
Q4 2022

Feb 08, 2023

SELL
$38.19 - $57.45 $11,686 - $17,579
-306 Reduced 0.65%
47,063 $1.82 Million
Q3 2022

Nov 14, 2022

BUY
$51.24 - $58.89 $139,885 - $160,769
2,730 Added 6.12%
47,369 $2.52 Million
Q2 2022

Aug 16, 2022

BUY
$51.49 - $81.64 $431,331 - $683,898
8,377 Added 23.1%
44,639 $2.6 Million
Q1 2022

May 13, 2022

BUY
$60.03 - $76.49 $720 - $917
12 Added 0.03%
36,262 $2.77 Million
Q4 2021

Feb 16, 2022

BUY
$47.97 - $62.21 $15,206 - $19,720
317 Added 0.88%
36,250 $2.18 Million
Q3 2021

Nov 15, 2021

SELL
$54.64 - $61.3 $3,114 - $3,494
-57 Reduced 0.16%
35,933 $2.01 Million
Q2 2021

Aug 19, 2021

SELL
$59.18 - $69.99 $2,485 - $2,939
-42 Reduced 0.12%
35,990 $2.18 Million
Q1 2021

May 17, 2021

BUY
$59.31 - $78.82 $4,270 - $5,675
72 Added 0.2%
36,032 $2.53 Million
Q4 2020

Feb 16, 2021

BUY
$50.47 - $66.26 $26,193 - $34,388
519 Added 1.46%
35,960 $2.15 Million
Q3 2020

Nov 10, 2020

BUY
$51.97 - $63.0 $9,614 - $11,655
185 Added 0.52%
35,441 $2.13 Million
Q2 2020

Aug 12, 2020

BUY
$30.8 - $52.47 $8,685 - $14,796
282 Added 0.81%
35,256 $1.85 Million
Q1 2020

May 15, 2020

BUY
$28.4 - $50.7 $49,586 - $88,522
1,746 Added 5.25%
34,974 $1.17 Million
Q4 2019

Feb 13, 2020

BUY
$36.31 - $46.83 $8,206 - $10,583
226 Added 0.68%
33,228 $1.51 Million
Q3 2019

Nov 14, 2019

BUY
$35.66 - $44.99 $1.18 Million - $1.48 Million
33,002 New
33,002 $1.26 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.